Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
White Paper
Mega Trends in Ancillary Services
Why Mega Trends Matter Mega trends are powerful, transformative shifts that have the potential to significantly affect the course of an i
Workers' Comp
Blog
2020 Year in Review
We can all agree that 2020 was a year filled with uncertainty, anxiety, and change.
Mitchell
Conference
WCRI 37th Annual Workers’ Comp Issues and Research Virtual Conference
The WCRI Annual Issues and
Mitchell
News Release
FDA Authorizes Second Coronavirus (SARS-CoV2) Vaccine for Use
On December 18, 2020, one week after authorizing the first SARS-CoV2 vaccine (Pfizer) for emergency use, the U.S.
Workers' Comp
Blog
Network 2.0 - Constructive partnerships between providers and payers
In our last blog post we discussed how networks help to manage the relationship with the provider and allow patients to sidest
Mitchell
News Release
Mitchell Predicts 2021 Trends in Its Fourth Quarter 2020 Industry Trends Report
SAN DIEGO, CA—Mitchell International, Inc., a leading provider of technology, connectivity and information solutions to the proper